Optimising immunosuppression

被引:7
作者
Schafer, DF [1 ]
Sorrell, MF [1 ]
机构
[1] Univ Nebraska, Liver Transplant Program, Omaha, NE USA
关键词
D O I
10.1016/S0140-6736(02)11237-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1114 / 1115
页数:2
相关论文
共 7 条
[1]   Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation [J].
Berenguer, M ;
Prieto, M ;
Rayón, JM ;
Mora, J ;
Pastor, M ;
Ortiz, V ;
Carrasco, D ;
San Juan, F ;
Burgueño, MDJ ;
Mir, J ;
Berenguer, J .
HEPATOLOGY, 2000, 32 (04) :852-858
[2]  
CALNE RY, 1979, LANCET, V2, P1033
[3]   A microemulsion of cyclosporine without intravenous cyclosporine in liver transplantation [J].
Hemming, AW ;
Greig, PD ;
Cattral, MS ;
Chung, SW ;
Lilly, LB ;
Aljumah, AA ;
Levy, GA .
TRANSPLANTATION, 1996, 62 (12) :1798-1802
[4]   Three-year follow-up of the European Multicenter Tacrolimus (FK506) Liver Study [J].
Pichlmayr, R ;
Winkler, M ;
Neuhaus, P ;
McMaster, P ;
Calne, R ;
Otto, G ;
Williams, R ;
Groth, CG ;
Bismuth, H .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (05) :2499-2502
[5]  
STARZL TE, 1989, LANCET, V2, P1000
[6]   LIVER-TRANSPLANTATION WITH USE OF CYCLOSPORIN-A AND PREDNISONE [J].
STARZL, TE ;
KLINTMALM, GBG ;
PORTER, KA ;
IWATSUKI, S ;
SCHROTER, GPJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (05) :266-269
[7]   A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation - A report of the United States FK506 study group [J].
Wiesner, RH .
TRANSPLANTATION, 1998, 66 (04) :493-499